180 Life Sciences Corp (ATNF) — Cash Flow-to-Debt Ratio
180 Life Sciences Corp (ATNF) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of $-16.30 Million could theoretically repay 0% of its total liabilities ($564.18 Million) in one year. See 180 Life Sciences Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
180 Life Sciences Corp Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for 180 Life Sciences Corp across 8 annual periods. Also explore net asset growth rate of 180 Life Sciences Corp to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for 180 Life Sciences Corp (2017–2024)
Year-by-year debt coverage analysis for 180 Life Sciences Corp. For market capitalisation and broader financial context, see 180 Life Sciences Corp market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $25.25 Million | ▲ +38.5% |
| 2019 | -0.25x | $-3.32 Million | $13.31 Million | ▼ -188.6% |
| 2018 | -0.09x | $-789.23K | $9.14 Million | ▲ +26.5% |
| 2017 | -0.12x | $-497.36K | $4.23 Million | — |